NCT01783691 Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD) Status COMPLETED Phase PHASE1
NCT01771731 Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01757418 Intravenous Gammaglobulin for Sickle Cell Pain Crises Status COMPLETED Phase PHASE1/PHASE2
NCT01737814 Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC) Status COMPLETED Phase PHASE3
NCT01736657 Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients Status COMPLETED Phase NA
NCT01732718 Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT01718054 Vascular Function Intervention Trial in Sickle Cell Disease Status UNKNOWN Phase PHASE2/PHASE3
NCT01702246 Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01685515 Study of Decitabine and Tetrahydrouridine (THU) in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT01673243 Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting Status COMPLETED Phase N/A
NCT01603160 Improving Emergency Department Management of Adults With Sickle Cell Disease Status COMPLETED Phase N/A
NCT01597401 A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT01591187 The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease Status COMPLETED Phase N/A
NCT01569971 Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program Status COMPLETED Phase N/A